Doktorgradsavhandling

• Camilla Hanquist Stokkevåg; Ludvig Paul Muren (2016). Model-based predictions of secondary cancer and late effect risks following particle therapy. (ekstern lenke)

Forelesning

• Johannes Tjelta; Lars Fredrik Fjæra; Kristian Smeland Ytre-Hauge et al. (2022). An approach for obtaining Monte Carlo computed dose and variable proton RBE from a treatment planning system. (ekstern lenke)

Konferanseabstrakt

• Tordis Johnsen Dahle; Anne Marit Rykkelid; Camilla Hanquist Stokkevåg et al. (2017). Monte Carlo simulations of a low-energy proton beam and estimation of LET distributions. (ekstern lenke)

Konferanseforedrag

• Erlend Lyngholm; Armin Lühr; Liheng Tian et al. (2024). Utilizing a neural network machine learning model for data-driven proton relative biological effectiveness modelling. (ekstern lenke)
• Erlend Lyngholm; Camilla Hanquist Stokkevåg; Armin Lühr et al. (2023). In vitro Data Selection Strongly impact RBE model predictions. (ekstern lenke)
• Erlend Lyngholm; Kristian Smeland Ytre-Hauge; Camilla Hanquist Stokkevåg (2023). Impact of an updated in vitro database on proton relative biological effectiveness modelling. (ekstern lenke)
• Camilla Hanquist Stokkevåg (2023). Image-based biomarkers of late effects. (ekstern lenke)
• Helge Henjum; Andreas Havsgård Handeland; Johannes Tjelta et al. (2022). Influence of beam pruning techniques on LET and RBE in proton arc therapy. (ekstern lenke)
• Johannes Tjelta; Lars Fredrik Fjæra; Kristian Smeland Ytre-Hauge et al. (2022). En systematisk metode for å beregne variabel RBE fra et doseplansystem for protonterapi ved hjelp av Monte Carlo. (ekstern lenke)
• Johannes Tjelta; Lars Fredrik Fjæra; Kristian Smeland Ytre-Hauge et al. (2022). A novel approach for obtaining Monte Carlo computed dose and variable RBE from a treatment planning system. (ekstern lenke)

Konferanseposter

• Karoline Mo Feten; Camilla Hanquist Stokkevåg; Camilla Grindeland Boer et al. (2024). Dosimetric comparison of proton arc therapy and intensity-modulated proton therapy for pediatric ependymoma patients. (ekstern lenke)
• Andreas Havsgård Handeland; Peter MT. Lægdsmand; Laura Toussaint et al. (2023). First application of an LET-inclusive NTCP model for brainstem necrosis following paediatric proton therapy in an independent cohort. (ekstern lenke)
• Andreas Havsgård Handeland; Peter MT. Lægdsmand; Laura Toussaint et al. (2023). Robustness evaluation of linear energy transfer in proton therapy of paediatric brain tumours. (ekstern lenke)
• Johannes Tjelta; Kristian Smeland Ytre-Hauge; Helge Henjum et al. (2023). Radiation-induced cancer risk from neutrons in pediatric proton therapy and field angle dependence. (ekstern lenke)
• Helge Henjum; Johannes Tjelta; Lars Fredrik Fjæra et al. (2023). Influnce of LET and RBE from including pruning techniques in proton arc therapy. (ekstern lenke)
• Johannes Tjelta; Kristian Smeland Ytre-Hauge; Helge Henjum et al. (2023). Radiation exposure to a parent-in-the-treatment-room during pencil beam scanning proton therapy. (ekstern lenke)
• Johannes Tjelta; Kristian Smeland Ytre-Hauge; Katia Parodi et al. (2023). The neutron contribution in pediatric proton therapy depends on field angle configuration. (ekstern lenke)
• Andreas Havsgård Handeland; Daniel J. Indelicato; Helge Henjum et al. (2023). Linear energy transfer based optimisation to minimise normal tissue complication probability in paediatric ependymomas. (ekstern lenke)
• Johannes Tjelta; Lars Fredrik Fjæra; Kristian Smeland Ytre-Hauge et al. (2022). A novel approach for obtaining Monte Carlo computed dose and variable proton RBE from a treatment planning system. (ekstern lenke)

Lederartikkel

• Grete May Engeseth; Camilla Hanquist Stokkevåg; Ludvig Paul Muren (2022). Achievements and challenges in normal tissue response modelling for proton therapy. (ekstern lenke)

Leserbrev

• Andreas Havsgård Handeland; Peter MT. Lægdsmand; Laura Toussaint et al. (2023). Linear energy transfer-inclusive brainstem necrosis risk models applied to an independent paediatric proton therapy cohort. (ekstern lenke)
• Johannes Tjelta; Kristian Smeland Ytre-Hauge; Erlend Lyngholm et al. (2023). Dose exposure to an adult present in the treatment room during pediatric pencil beam scanning proton therapy. (ekstern lenke)
• Laura Toussaint; Daniel J. Indelicato; Ludvig Paul Muren et al. (2021). Response to: ‘Comments on “Temporal lobe sparing radiotherapy with photons or protons for cognitive function preservation in paediatric craniopharyngioma” by Toussaint, et al.: Prior similar field arrangement work and a need for variable RBE Use’. (ekstern lenke)

Vitenskapelig artikkel

• Erlend Lyngholm; Armin Lühr; Liheng Tian et al. (2026). Neural network modelling of proton RBE values at predominant survival fractions of in vitro data. (ekstern lenke)
• Johannes Tjelta; Kristian Smeland Ytre-Hauge; Franz Siegfried Englbrecht et al. (2025). Neutron contribution depending on the treatment room during pediatric pencil beam scanning proton therapy. (ekstern lenke)
• Johan Martin Søbstad; Turid Husevåg Sulen; Helge Egil Seime Pettersen et al. (2025). Time efficiency, geometric accuracy, and clinical impact of AI-assisted contouring of organs at risk in head and neck cancer radiotherapy. (ekstern lenke)
• Rasmus Klitgaard; Lars Fredrik Fjæra; Camilla Hanquist Stokkevåg et al. (2025). Modelling of a double-scattering proton therapy nozzle using the FLUKA Monte Carlo code and analysis of linear energy transfer in patients treated for prostate cancer. (ekstern lenke)
• Helge Henjum; Karoline Mo Feten; Erlend Hartvigsen et al. (2025). Dosimetric comparison of intensity-modulated proton therapy and proton arc therapy for pediatric ependymoma. (ekstern lenke)
• Camilla Hanquist Stokkevåg; Neige Journy; Ivan R. Vogelius et al. (2024). Radiation Therapy Technology Advances and Mitigation of Subsequent Neoplasms in Childhood Cancer Survivors. (ekstern lenke)
• Erlend Lyngholm; Camilla Hanquist Stokkevåg; Armin Lühr et al. (2024). An updated variable RBE model for proton therapy. (ekstern lenke)
• Helge Henjum; Johannes Tjelta; Lars Fredrik Fjæra et al. (2023). Influence of beam pruning techniques on LET and RBE in proton arc therapy. (ekstern lenke)
• Laura Toussaint; Daniel J Indelicato; Ludvig Paul Muren et al. (2023). Risk of second primary cancer from proton arc therapy of pediatric brain tumors. (ekstern lenke)
• Johannes Tjelta; Lars Fredrik Fjæra; Kristian Smeland Ytre-Hauge et al. (2023). A systematic approach for calibrating a Monte Carlo code to a treatment planning system for obtaining dose, LET, variable proton RBE and out-of-field dose. (ekstern lenke)
• Helge Henjum; Tordis Johnsen Dahle; Andrea Mairani et al. (2023). Combined RBE and OER optimization in proton therapy with FLUKA based on EF5-PET. (ekstern lenke)
• Andreas Havsgård Handeland; Daniel J. Indelicato; Lars Fredrik Fjæra et al. (2023). Linear energy transfer-inclusive models of brainstem necrosis following proton therapy of paediatric ependymoma. (ekstern lenke)
• Lars Fredrik Fjæra; Daniel J. Indelicato; Andreas Havsgård Handeland et al. (2022). A case-control study of linear energy transfer and relative biological effectiveness related to symptomatic brainstem toxicity following pediatric proton therapy. (ekstern lenke)
• Grete May Engeseth; Liv Bolstad Hysing; Pablo Yepes et al. (2022). Impact of RBE variations on risk estimates of temporal lobe necrosis in patients treated with intensity-modulated proton therapy for head and neck cancer. (ekstern lenke)
• Helge Henjum; Tordis Johnsen Dahle; Lars Fredrik Fjæra et al. (2021). The Organ Sparing Potential of Different Biological Optimization Strategies in Proton Therapy. (ekstern lenke)
• Grete May Engeseth; Renjie He; Dragan Mirkovic et al. (2021). Mixed Effect Modeling of Dose and Linear Energy Transfer Correlations With Brain Image Changes After Intensity Modulated Proton Therapy for Skull Base Head and Neck Cancer. (ekstern lenke)
• Kristian Ytre-Hauge; Lars Fredrik Fjæra; Eivind Rørvik et al. (2020). Inter-patient variations in relative biological effectiveness for cranio-spinal irradiation with protons. (ekstern lenke)
• Ole Marius Otterlei; Daniel J. Indelicato; Laura Toussaint et al. (2020). Variation in relative biological effectiveness for cognitive structures in proton therapy of pediatric brain tumors. (ekstern lenke)
• Lars Fredrik Fjæra; Daniel J. Indelicato; Kristian Ytre-Hauge et al. (2020). Spatial agreement of brainstem dose distributions depending on biological model in proton therapy for pediatric brain tumors. (ekstern lenke)
• Lars Fredrik Fjæra; Daniel J. Indelicato; Camilla Hanquist Stokkevåg et al. (2020). Implementation of a double scattering nozzle for Monte Carlo recalculation of proton plans with variable relative biological effectiveness. (ekstern lenke)
• Tordis Johnsen Dahle; Espen Rusten; Camilla Hanquist Stokkevåg et al. (2020). The FLUKA Monte Carlo code coupled with an OER model for biologically weighted dose calculations in proton therapy of hypoxic tumors. (ekstern lenke)
• Grete May Engeseth; Sonja Stieb; Abdallah Sherif Radwan Mohamed et al. (2020). Outcomes and patterns of radiation associated brain image changes after proton therapy for head and neck skull base cancers. (ekstern lenke)
• Laura Toussaint; Daniel J. Indelicato; Camilla Hanquist Stokkevåg et al. (2019). Radiation doses to brain substructures associated with cognition in radiotherapy of pediatric brain tumors. (ekstern lenke)
• Laura Toussaint; Daniel J. Indelicato; Ludvig Paul Muren et al. (2019). Temporal lobe sparing radiotherapy with photons or protons for cognitive function preservation in paediatric craniopharyngioma. (ekstern lenke)
• Camilla Hanquist Stokkevåg; Daniel J. Indelicato; Klaus Herfarth et al. (2019). Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy. (ekstern lenke)
• Kristian Ytre-Hauge; Arild Velure; Camilla Hanquist Stokkevåg et al. (2019). First application of a novel SRAM-based neutron detector for proton therapy. (ekstern lenke)
• Laura Toussaint; Daniel J. Indelicato; Katrine S. Holgersen et al. (2019). Towards proton arc therapy: physical and biologically equivalent doses with increasing number of beams in pediatric brain irradiation. (ekstern lenke)
• Tordis Johnsen Dahle; Giuseppe Magro; Kristian Ytre-Hauge et al. (2018). Sensitivity study of the microdosimetric kinetic model parameters for carbon ion radiotherapy. (ekstern lenke)
• Eivind Rørvik; Lars Fredrik Fjæra; Tordis Johnsen Dahle et al. (2018). Exploration and application of phenomenological RBE models for proton therapy. (ekstern lenke)
• Lars Fredrik Fjæra; Zuofeng Li; Kristian Ytre-Hauge et al. (2017). Linear energy transfer distributions in the brainstem depending on tumour location in intensity-modulated proton therapy of paediatric cancer. (ekstern lenke)
• Eivind Rørvik; Sara Thørnqvist; Camilla Hanquist Stokkevåg et al. (2017). A phenomenological biological dose model for proton therapy based on linear energy transfer spectra. (ekstern lenke)
• Jesper Pedersen; Jørgen Brede Baltzer Petersen; Camilla Hanquist Stokkevåg et al. (2017). Biological dose and complication probabilities for the rectum and bladder based on linear energy transfer distributions in spot scanning proton therapy of prostate cancer. (ekstern lenke)
• Tordis Johnsen Dahle; Anne Marit Rykkelid; Camilla Hanquist Stokkevåg et al. (2017). Monte Carlo simulations of a low energy proton beamline for radiobiological experiments. (ekstern lenke)
• Camilla Hanquist Stokkevåg; Grete May Engeseth; Liv Bolstad Hysing et al. (2017). The influence of inter-fractional anatomy variation on secondary cancer risk estimates following radiotherapy. (ekstern lenke)
• Camilla Hanquist Stokkevåg; Mai Fukahori; Takuma Nomiya et al. (2016). Modelling of organ-specific radiation-induced secondary cancer risks following particle therapy. (ekstern lenke)
• Camilla Hanquist Stokkevåg; Grete May Engeseth; Liv Bolstad Hysing et al. (2015). Risk of radiation-induced secondary rectal and bladder cancer following radiotherapy of prostate cancer. (ekstern lenke)
• Kristian Ytre-Hauge; Arild Velure; Eivind Farestveit Larsen et al. (2015). Design and characterization of an SRAM-based neutron detector for particle therapy. (ekstern lenke)
• Camilla Stokkevåg; Grete May Engeseth; Kristian Ytre-Hauge et al. (2014). Estimated risk of radiation-induced cancer following paediatric cranio-spinal irradiation with electron, photon and proton therapy. (ekstern lenke)
• Kenneth Aamodt; B Abelev; AA Quintana et al. (2011). Higher harmonic anisotropic flow measurements of charged particles in Pb-Pb collisions at root s(NN)=2.76 TeV. (ekstern lenke)
• Sergey Gorbunov; David Rohr; Kenneth Aamodt et al. (2011). ALICE HLT High Speed Tracking on GPU. (ekstern lenke)
• Kenneth Aamodt; AA Quintana; D Adamova et al. (2011). Rapidity and transverse momentum dependence of inclusive J/psi production in pp collisions at root s=7 TeV. (ekstern lenke)
• Kenneth Aamodt; Larissa Bravina; Olja Dordic et al. (2010). Elliptic Flow of Charged Particles in Pb-Pb Collisions at \sqrt{s_{NN}} = 2.76 TeV. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Camilla Hanquist Stokkevåg; Uwe Schneider; Ludvig Paul Muren et al. (2017). Radiation-induced cancer risk predictions in proton and heavy ion radiotherapy. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.

Publikasjoner i Cristin

https://www.scopus.com/authid/detail.uri?authorId=36683123500